Abstract: Self-preserved nasal, inhalable and topical ophthalmic preparations and medications which destroy, inhibit or therapeutically significantly limit microbial growth within said preparations or medications. The nasal, inhalable, and topical ophthalmic preparations and medications have been found to be stable without buffer and maintain a stable pH at pH 3.5 or lower. They are well tolerated by patients.

Abstract: Self-preserved nasal, inhalable and topical ophthalmic preparations and medications which destroy, inhibit or therapeutically significantly limit microbial growth within said preparations or medications. The nasal, inhalable, and topical ophthalmic preparations and medications are mildly buffered and maintain a stable pH at pH 3.5 or lower.

Abstract: Self-preserved nasal, inhalable and topical ophthalmic preparations and medications which destroy, inhibit or therapeutically significantly limit microbial growth within said preparations or medications. The nasal, inhalable, and topical ophthalmic preparations and medications are mildly buffered and maintain a stable pH at pH 3.5 or lower.

Abstract: Self-preserved nasal, inhalable and topical ophthalmic preparations and medications which destroy, inhibit or therapeutically significantly limit microbial growth within said preparations or medications. The nasal, inhalable, and topical ophthalmic preparations and medications are mildly buffered and maintain a stable pH at pH 3.5 or lower.

Abstract: A preparation suitable for sustained and extended corneal analgesia and for repeated administration consisting of ultralow nontoxic subanaesthetic concentrations of local anesthetic agents. A method for corneal analgesia has a fast onset of pain relief and extended duration of the corneal analgesia for several months without accompanying toxic symptoms by administering to a patient an ophthalmic analgesic solution containing a local anesthetic agent in subanesthetic concentration.

Abstract: A method for sustained and extended corneal analgesia by repeated administration of ophthalmic analgesic solutions or preparations containing ultralow nontoxic subanesthetic concentrations of local anesthetic agents. A method for corneal analgesia has a fast onset of pain relief and extended duration of the corneal analgesia for several months without accompanying toxic symptoms by administering to a patient an ophthalmic analgesic solution containing a local anesthetic agent in ultralow concentration between about 0.001% and about 0.05%.

Abstract: A surgical knife assembly in which the handle portion tapers down and is truncated obliquely at a selected angle to form a blade guard surface. The blade of this knife has a dull edge and a sharpened edge which meet in a point with an acute included angle. This blade is affixed to the blade guard surface so that the dull edge of the blade intersects the straight edge of the blade guard surface with the side portions of the blade being perpendicular to that same straight edge. In addition, when the blade is affixed to the blade guard surface, the dull edge of the blade is mounted so that it is substantially parallel to the major axis of the handle. To insert the blade in the surface where the incision is to be made, the knife is designed so that the user will hold the surgical knife so that the guard surface is substantially parallel to the surface to be cut.